RecruitingNot ApplicableNCT05269589

Home-based Heat Therapy for Type 2 Diabetes

Impact of a Home-based Heat Therapy Intervention on Markers of Cardiometabolic Function in Adults with Type 2 Diabetes


Sponsor

Montreal Heart Institute

Enrollment

44 participants

Start Date

Feb 18, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Insulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in individuals with T2DM persists despite optimal pharmacological therapy, highlighting the need to identify complementary lifestyle interventions that improve cardiometabolic functions in this population. Evidence from animal models suggests that heat exposure improves metabolic functions. Notably, weekly heat exposure for 16 weeks blunts hyperinsulinemia and hyperglycemia induced by a high fat diet in mice. In parallel, studies in humans have shown that heat exposure improves vascular endothelial function. Based on such findings, it has been suggested that heat therapy may represent an effective lifestyle intervention to improve cardiometabolic functions. However, only 1 study has examined the impact of a heat therapy intervention on individuals with T2DM, demonstrating that 6 weeks of heat exposure reduces fasting plasma glucose and hemoglobin A1C. No study has considered potential vascular benefits of heat therapy in individuals with T2DM. This project will investigate cardiometabolic responses to repeated heat exposure in men and women with T2DM. We will test the hypothesis that 12 weeks of heat therapy improves postprandial fatty acid handling, insulin sensitivity and endothelial function in individuals with T2DM.


Eligibility

Min Age: 45 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether regular warm baths or soaking at home (heat therapy) can improve blood sugar control and other health markers in people with type 2 diabetes. **You may be eligible if...** - You are 45–75 years old - You have had type 2 diabetes for at least 1 year - Your medication has been stable for at least 12 weeks **You may NOT be eligible if...** - You use insulin therapy - You have severe obesity (Class 3) - You have uncontrolled high blood pressure - You have heart, kidney, or lung disease - You have severe nerve damage (neuropathy) or eye disease (retinopathy) - Your triglycerides or cholesterol levels are very high Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThermoneutral water

Participants will immerse their feet in a foot bath that contains thermoneutral water

OTHERHot water

Participants will immerse their feet in a foot bath that contains hot water


Locations(1)

Centre ÉPIC, Montreal Heart Institute

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05269589


Related Trials